Publicacións en colaboración con investigadores/as de Hammersmith Hospital (6)

2021

  1. Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function

    Translational Psychiatry, Vol. 11, Núm. 1

  2. Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function (Translational Psychiatry, (2021), 11, 1, (579), 10.1038/s41398-021-01705-z)

    Translational Psychiatry

  3. Inflammatory and cardiometabolic markers at presentation with first episode psychosis and long-term clinical outcomes: A longitudinal study using electronic health records

    Brain, Behavior, and Immunity, Vol. 91, pp. 117-127

  4. Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes

    Neuropsychopharmacology, Vol. 46, Núm. 8, pp. 1468-1474

2020

  1. Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study

    Neuropsychopharmacology, Vol. 45, Núm. 4, pp. 641-648

2019

  1. Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia?

    BMJ Case Reports, Vol. 12, Núm. 3